Rajen Shah

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Felbamate has been approved for refractory partial seizures since the early nineties. Due to safety concerns regarding its use, namely, in aplastic anemia and hepatic failure, felbamate's use has been restricted and a 'Black Box' warning has been inserted. Nonetheless, it is a useful drug in refractory cases of partial epilepsy. There are certain(More)
Pharmacokinetic studies for proving bioequivalence of orally inhaled drug products—critical issues and concepts. Front. Pharmacol. 6:117. The inhalational drug market, especially the generic market, has a tremendous growth potential are drugs that are bioequivalent to the approved drugs. The United States Food and Drug Administration (FDA) has defined(More)
  • 1